Q1 Earnings Estimate for AXSM Issued By Leerink Partnrs
Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) – Analysts at Leerink Partnrs issued their Q1 2025 EPS estimates for shares of Axsome Therapeutics in a research report issued on Monday, February 10th. Leerink Partnrs analyst M. Goodman forecasts that the company will earn ($1.48) per share for the quarter. The consensus estimate for Axsome Therapeutics’ […]
